國家衛生研究院 NHRI:Item 3990099045/11956

NHRI > Institute of Molecular and Genomic Medicine > Shiu-Feng Kathy Huang > Periodical Articles > Item 3990099045/11956

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11956

Title:	Effects of hepatic steatosis on non-invasive liver fibrosis measurements between hepatitis B and other etiologies
Authors:	Chen, CJ;Tsay, PK;Huang, SF;Tsui, PH;Yu, WT;Hsu, TH;Tai, J;Tai, DI
Contributors:	Institute of Molecular and Genomic Medicine
Abstract:	Fibrosis-4 (FIB4), transient elastography (TE), and acoustic radiation force impulse (ARFI) are popular modalities to assess liver fibrosis. Their cutoff values for degrees of fibrosis vary between studies. The influence of hepatic steatosis on fibrosis measurements for different etiologies was evaluated. Data from a consecutive series of patients who received fibrosis measurement were included for the training group. An additional series with histology served as the validation group. A standardized protocol was performed for both TE and ARFI, mostly by a single technician. Patients with alcoholism, autoimmune disease, active inflammation, or who were receiving therapy were excluded. The training group included 215 patients and the validation group included 221. The correlation of liver stiffness between TE and ARFI was good (R-2 linear = 0.798; p < 0.001). Different correlations between ARFI and TE were noted between high and low control attenuation parameter (CAP) values (cutoff: 290 dB/m), especially in the non-hepatitis B subgroups. Relatively lower FIB4 and TE values were seen in the high CAP versus low CAP in patients with histology-proven non-alcoholic fatty liver disease and chronic hepatitis C. FIB4 cutoff values were >25% lower among F2-F4 stages and the TE cutoff value for F4 was 8.5% lower in the high versus low CAP group. Such findings were not observed in chronic hepatitis B. Different fibrogenesis mechanisms between hepatitis B and non-B are discussed. We conclude that hepatic steatosis significantly impacts FIB4 and TE fibrosis measurements in non-hepatitis B-related liver diseases. Fibrosis grade should be interpreted with caution in severe steatosis.
Date:	2019-05
Relation:	Applied Sciences-Basel. 2019 May;9(9):Article number 1961.
Link to:	http://dx.doi.org/10.3390/app9091961
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2076-3417&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000469756000240
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85067178189
Appears in Collections:	[Shiu-Feng Kathy Huang] Periodical Articles

Files in This Item:

File	Size	Format
ISI000469756000240.pdf	720Kb	Adobe PDF	310	View/Open

Loading...